Medication info
Pitavastatin Calcium Tablet

Pitavastatin Calcium Tablet

Prescription medicationTabletOral
Ingredient · strength
Pitavastatin Calcium›2mg / 1 tablet
Manufacturer / importer
Samnam Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201103419 · Approved 2011.05.24 · Insurance code 653701940

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medication. The usual initial dose for adults is 1~2 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 mg daily. The dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response, and the therapeutic effect of this medication is maintained with continued administration.

Ingredients

Manufacturer
Samnam Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated Apo-B protein
  • elevated triglycerides
View approved original text

This medication is used in conjunction with diet therapy in patients with primary hypercholesterolemia and mixed dyslipidemia, helping to reduce elevated total cholesterol, LDL cholesterol, Apo-B protein, and triglyceride levels. It also plays a role in increasing HDL cholesterol levels, improving blood lipid balance. This drug is particularly effective for type IIa and IIb symptoms according to Fredrickson classification and helps contribute to lowering the risk of cardiovascular diseases. Patients are advised that consistent use alongside dietary management will be greatly beneficial in managing dyslipidemia.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this medication. The usual initial dose for adults is 1~2 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 mg daily. The dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response, and the therapeutic effect of this medication is maintained with continued administration.

Precautions

This medication should not be used in patients who are allergic to certain components. Patients with active liver diseases or severely impaired liver function, and those with bile duct obstruction should not take this medication. Patients on cyclosporine or those with myopathy should also avoid this drug. The safety during pregnancy or in women who may become pregnant, nursing mothers, and children is not established, hence, it is not administered. Patients with specific genetic metabolic abnormalities such as lactose intolerance should not take this medication. Patients with renal function issues or a history of liver disease need to use this drug cautiously, especially in combination with fibrates or niacin, as there is a high risk of muscle damage. Caution is also required for elderly patients or those with hypothyroidism or a history of muscle diseases. If muscle pain, weakness, or symptoms of liver dysfunction appear during this medication, immediate consultation with healthcare professionals is necessary. It is important to regularly undergo blood tests and liver function tests to check for abnormalities. This medication may interact with other drugs; therefore, it is crucial to inform healthcare professionals, especially when used in conjunction with cyclosporine, fibrates, niacin, or erythromycin. It is recommended to avoid excessive alcohol consumption during treatment and to follow a diet and exercise regimen. Keep this medication out of reach of children and store it in its original container. Women who are pregnant or planning to become pregnant should not take this medication, and if pregnancy is confirmed during treatment, it should be discontinued immediately. Accurate diagnosis and tests are required before administering this drug, which is used for treating hypercholesterolemia. If any abnormal symptoms occur during treatment, consultation with a physician is necessary to receive appropriate measures.

Side effects

  • Abdominal pain
  • rash
  • lethargy
  • paralysis
  • itching
  • myalgia
  • weakness
  • increased CPK levels
  • elevated myoglobin in blood and urine
  • acute renal failure
Show 79 more
  • liver dysfunction
  • jaundice
  • thrombocytopenia
  • urticaria
  • erythema
  • angioedema
  • elevated bilirubin
  • increased cholinesterase
  • elevated AST
  • elevated ALT
  • elevated γ-GT
  • elevated ALP
  • elevated LDH
  • stiffness
  • drowsiness
  • insomnia
  • headache
  • heaviness in the head
  • dizziness
  • thirst
  • dyspepsia
  • abdominal bloating
  • constipation
  • stomatitis
  • vomiting
  • loss of appetite
  • glossitis
  • nausea
  • gastric discomfort
  • diarrhea
  • neutropenia
  • leukopenia
  • eosinophilia
  • leukocytosis
  • elevated globulin
  • positive Coombs test
  • anemia
  • frequent urination
  • increased BUN
  • elevated serum creatinine
  • decreased aldosterone
  • increased aldosterone
  • elevated adrenocorticotropic hormone
  • elevated cortisol
  • decreased testosterone
  • muscle cramps
  • weakness
  • palpitations
  • fatigue
  • skin pain
  • burning sensation
  • arthralgia
  • edema
  • blurred vision
  • photophobia
  • hearing loss
  • hematuria
  • increased uric acid levels
  • elevated serum potassium and phosphorus
  • taste disturbance
  • positive antinuclear antibodies
  • sleep disturbances
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes
  • immune-mediated necrotizing myopathy
  • facial swelling
  • arm swelling
  • hypersensitivity
  • headache
  • dizziness
  • skin tingling
  • insomnia
  • loss of appetite
  • increased blood pressure
  • chest discomfort
  • weakness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that can block light. Additionally, the medication should be stored at room temperature between 1°C and 30°C, avoiding too hot or too cold places.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.